406 related articles for article (PubMed ID: 10203100)
21. [Studies on molecular markers for hemostasis and thrombosis in various renal diseases].
Shibata T; Ishii T; Tomo T; Kaneko K; Nasu M; Magari Y; Fukushima K
Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):373-8. PubMed ID: 1831516
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. colisepsis--toward a distinction between uncompensated overt DIC and compensated non-overt DIC.
Wada H; Yamamuro M; Inoue A; Shiku H; Sakuragawa N; Redl H; Peer G; Taylor FB
Thromb Haemost; 2001 Dec; 86(6):1489-94. PubMed ID: 11776318
[TBL] [Abstract][Full Text] [Related]
23. [Plasma fibrin monitor level in DIC patients with a hematopoietic malignancy].
Hiyoyama K; Wada H; Shimura M; Deguchi H; Nagaya S; Wakita Y; Deguchi K; Shiku H
Rinsho Byori; 1996 Jan; 44(1):57-60. PubMed ID: 8691641
[TBL] [Abstract][Full Text] [Related]
24. Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Deguchi H; Mori Y; Kaneko T; Deguchi K; Fujii J; Shiku H
Am J Hematol; 1996 Apr; 51(4):255-60. PubMed ID: 8602623
[TBL] [Abstract][Full Text] [Related]
25. Increased hemostatic molecular markers in patients undergoing anticoagulant therapy.
Wada H; Ikuma H; Mori Y; Shimura M; Hiyoyama K; Nakasaki T; Onoda K; Yamada N; Ohta T; Nishioka J; Sakuragawa N; Shiku H
Semin Thromb Hemost; 2000; 26(1):113-8. PubMed ID: 10805292
[TBL] [Abstract][Full Text] [Related]
26. Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation.
Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi K; Shirakawa S; Hayashi T
Am J Hematol; 1993 Oct; 44(2):85-8. PubMed ID: 8266924
[TBL] [Abstract][Full Text] [Related]
27. Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations.
Yamada S; Asakura H
Int J Hematol; 2021 Jan; 113(1):15-23. PubMed ID: 33175341
[TBL] [Abstract][Full Text] [Related]
28. Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC.
Taylor FB; Wada H; Kinasewitz G
Crit Care Med; 2000 Sep; 28(9 Suppl):S12-9. PubMed ID: 11007191
[TBL] [Abstract][Full Text] [Related]
29. [Diagnosis of DIC based on evidence].
Wada H; Nishioka J; Nobori T; Sakaguchi A; Abe Y
Rinsho Byori; 2006 Nov; 54(11):1172-7. PubMed ID: 17240840
[TBL] [Abstract][Full Text] [Related]
30. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.
Kario K; Matsuo T; Kodama K; Matsuo M; Yamamoto K; Kobayashi H
Haemostasis; 1992; 22(4):179-86. PubMed ID: 1468720
[TBL] [Abstract][Full Text] [Related]
31. Anti-heparin/PF4 complexes by ELISA in patients with disseminated intravascular coagulation.
Matsuo T; Matsuo M; Sugimoto T; Wanaka K
Pathophysiol Haemost Thromb; 2007; 36(6):305-10. PubMed ID: 20224256
[TBL] [Abstract][Full Text] [Related]
32. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.
Asakura H; Ontachi Y; Mizutani T; Kato M; Saito M; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Nakao S
Crit Care Med; 2001 Jun; 29(6):1164-8. PubMed ID: 11395595
[TBL] [Abstract][Full Text] [Related]
33. Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study.
Mei H; Jiang Y; Luo L; Huang R; Su L; Hou M; Wang X; Deng J; Hu Y
Thromb Res; 2019 Jan; 173():20-26. PubMed ID: 30458338
[TBL] [Abstract][Full Text] [Related]
34. Hypercoagulability and DIC in high-risk infants.
Suzuki S; Morishita S
Semin Thromb Hemost; 1998; 24(5):463-6. PubMed ID: 9834014
[TBL] [Abstract][Full Text] [Related]
35. Disseminated intravascular coagulation in transfusion-associated graft-versus-host disease. Report of two cases.
Murakawa M; Okamura T; Harada M; Esaki T; Kamura T; Shibuya T; Niho Y
Ann Clin Lab Sci; 1995; 25(1):31-8. PubMed ID: 7762966
[TBL] [Abstract][Full Text] [Related]
36. Prednisolone inhibits endotoxin-induced disseminated intravascular coagulation and improves mortality in rats: importance of inflammatory cytokine suppression.
Yamazaki M; Aoshima K; Mizutani T; Ontachi Y; Saito M; Morishita E; Asakura H; Matsuda T; Triplett DA
Blood Coagul Fibrinolysis; 1999 Sep; 10(6):321-30. PubMed ID: 10493213
[TBL] [Abstract][Full Text] [Related]
37. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation].
Fukuda C; Iijima K; Nakamura K
Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061
[TBL] [Abstract][Full Text] [Related]
38. Posttrauma coagulation and fibrinolysis.
Gando S; Tedo I; Kubota M
Crit Care Med; 1992 May; 20(5):594-600. PubMed ID: 1533358
[TBL] [Abstract][Full Text] [Related]
39. Hemostatic abnormalities in patients with thrombotic complications on maintenance hemodialysis.
Inoue A; Wada H; Takagi M; Yamamuro M; Mukai K; Nakasaki T; Shimura M; Hiyoyama K; Deguchi H; Gabazza EC; Mori Y; Nishikawa M; Deguchi K; Shiku H
Clin Appl Thromb Hemost; 2000 Apr; 6(2):100-3. PubMed ID: 10775031
[TBL] [Abstract][Full Text] [Related]
40. [Clinical significance of thrombin-antithrombin III complex and plasmin-alpha 2 plasmin inhibitor complex in chronic liver diseases].
Ohmoto K; Yamamoto S; Ideguchi S; Yamamoto R; Takatori K; Ohumi T; Hino K; Hirano Y
Nihon Shokakibyo Gakkai Zasshi; 1990 Sep; 87(9):1837-45. PubMed ID: 2147451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
